Ovarian Cancer Research Samples
8 Results
1 - 8 of 8 total samples.
Advanced Data View:
1 - 8 of 8 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Stage | Treatment Status | Site of Primary Disease 1 | Specific Diagnosis 1 | Primary/Metastatic | Malignant/Benign |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71V3F64O6A | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 59 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 70 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Metastatic | Malignant | |||
| AQKJG822F3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 71 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 49 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | II | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||
| F2GT7B4DVM | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 71 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 95 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||
| F5G8YKU4X3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 79 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 64 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | N/A | N/A | Ovary | Sebaceous carcinoma | Primary | Malignant | |||
| KUKQ0UGLY9 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 50 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 61 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||
| O9YPGX6W4L | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 66 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 196 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | IV | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||
| OAH1AA93DS | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 35 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 215 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Endometrioid carcinoma | Primary | Malignant | |||
| PCVUGM3ZV3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 70 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 60 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | IV | N/A | Ovary | Serous carcinoma | Metastatic | Malignant |